Clinical Trial

NIV Versus HFO for Acute Exacerbations of Interstitial Lung Diseases

Name: NIV Versus HFO for Acute Exacerbations of Interstitial Lung Diseases — clinical trial record (NCT06182956)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: IRAPIDPhysio

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

The objectives of this study are to compare the physiological consequences of high-flow oxygen therapy and noninvasive mechanical ventilation on ventilation, respiratory work and hemodynamics during acute respiratory failure in diffuse interstitial pneumonia.

Trial Details

NCT Number	NCT06182956
Lead Sponsor	ADIR Association
Conditions	Interstitial Lung Disease, Acute Respiratory Failure
Enrollment	18 participants
Start Date	2024-01-01
Primary Completion	2026-12-31 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2023-12-27